RYBELSUS® Patient Information Leaflet (external link) - PIL

RYBELSUS® Summary of Product Characteristics (external link) - SmPC

RYBELSUS® European Public Assessment Report (external link) - EPAR

 This medicine is subject to additional safety monitoring.  This will allow quick identification of new safety information.  You can help by reporting any side effects you may get.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.  

This page is intended for members of the UK public